Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bristol-Myers Squibb Company - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BMY
New York
2830
www.bms.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bristol-Myers Squibb Company
BioArctic AB (BRCTF) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Profitability ...
- Feb 14th, 2025 7:04 am
Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial
- Feb 13th, 2025 9:16 pm
Bristol-Myers Squibb Company (BMY) – Jim Cramer: “No, No, You Don’t Hold”
- Feb 12th, 2025 9:05 pm
Shareholders in Bristol-Myers Squibb (NYSE:BMY) have lost 7.2%, as stock drops 5.4% this past week
- Feb 12th, 2025 12:00 pm
BMY Down 7% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?
- Feb 11th, 2025 6:52 pm
Jim Cramer on Bristol-Myers (BMY): Cobenfy’s Success vs. Patent Headwinds
- Feb 11th, 2025 5:11 pm
BMS’ Phase II trial of CAR T cell therapy meets primary endpoint
- Feb 11th, 2025 10:42 am
The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.
- Feb 11th, 2025 10:30 am
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
- Feb 10th, 2025 2:00 pm
Royalty Pharma Earnings: What To Look For From RPRX
- Feb 10th, 2025 1:03 pm
Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (lisocabtagene maraleucel) in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma
- Feb 10th, 2025 11:59 am
Jim Cramer on Bristol Myers (BMY): “Knocking It Out of the Park” – Is the Comeback Legit?
- Feb 8th, 2025 11:58 pm
Bristol-Myers Squibb Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
- Feb 8th, 2025 12:13 pm
Bristol-Myers Squibb Co (BMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
- Feb 7th, 2025 7:07 am
Q4 2024 Bristol-Myers Squibb Co Earnings Call
- Feb 7th, 2025 5:35 am
Bristol-Myers Squibb stock in focus on weak outlook
- Feb 6th, 2025 10:03 pm
Bristol Myers Wallops Fourth-Quarter Views, But Shares Slide On 2025 Outlook
- Feb 6th, 2025 9:03 pm
Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
- Feb 6th, 2025 6:30 pm
Jim Cramer on Bristol-Myers Squibb (BMY): “First Schizophrenia Drug in 30 Years”
- Feb 6th, 2025 5:59 pm
BMY Q4 Earnings and Sales Beat Estimates, Shares Down on 2025 Outlook
- Feb 6th, 2025 5:10 pm
Scroll